Literature DB >> 26502853

Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.

W-H Sheng1, K-T Sheng, Y-X Zhao, H Li, J-L Zhou, H-Y Yao, X-H Li.   

Abstract

OBJECTIVE: miRNAs are key regulators in multiple sclerosis. To gain a better understanding of the molecular mechanisms of multiple sclerosis, differentially expressed microRNAs (DE-miRNAs) and genes (DEGs) were analyzed.
MATERIALS AND METHODS: The miRNA expression profile GSE43590 including 11 samples of peripheral blood T-cells from relapsing-remitting MS patients and 9 normal samples as well as gene expression profile GSE52139 including 8 periplaque samples and 8 normal samples were downloaded from Gene Expression Omnibus. Then, DE-miRNAs and DEGs were identified using limma. Moreover, the target genes of DE-miRNAs were screened. Additionally, the integrated regulatory network of DEGs, DE-miRNAs and targets was constructed using Cytoscape. What's more, the functional modules were also screened using MINE in Cytoscape. Lastly, the functional annotation of genes in modules was conducted using DAVID.
RESULTS: A total of 2394 DEGs were screened in 8 periplaque samples. Additionally, 296 DE-miRNAs were identified in the 11 samples of peripheral blood T-cells from relapsing-remitting MS patients. Besides, 6 functional modules (A-F) were screened. Among them, has-miR-197 could target HNF4A. What's more, HNF4A could interact with CYP3A4. Additionally, has-miR-125b could target ID1 and ID3. Besides, ID1 could interact with THBS1. Furthermore, functional enrichment showed that CYP3A4 was significantly related to vitamin metabolic process. For the pathway enrichment, ID1 and ID3 were significantly enriched in TGF-beta signaling pathway.
CONCLUSIONS: Some important DE-miRNAs (such as has-miR-197and has-miR-125b) might be crucial for MS by regulating the expressions of their target genes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26502853

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients.

Authors:  M Pazhouhandeh; M-A Sahraian; S D Siadat; A Fateh; F Vaziri; F Tabrizi; F Ajorloo; A K Arshadi; E Fatemi; S Piri Gavgani; F Mahboudi; F Rahimi Jamnani
Journal:  Clin Exp Immunol       Date:  2018-01-25       Impact factor: 4.330

2.  Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.

Authors:  Samuel Brennan; Matthew Keon; Bing Liu; Zheng Su; Nitin K Saksena
Journal:  Mol Neurobiol       Date:  2019-04-29       Impact factor: 5.590

3.  Bioinformatic analysis of retinal gene function and expression in diabetic rats.

Authors:  Wenjuan Zhao; Dong Wang; Jun Zhao; Wenqing Zhao
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

Review 4.  Small RNAs, Big Diseases.

Authors:  Iwona Rzeszutek; Aditi Singh
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

5.  Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis.

Authors:  Hani Sabaie; Zoha Salkhordeh; Mohammad Reza Asadi; Soudeh Ghafouri-Fard; Nazanin Amirinejad; Mahla Askarinejad Behzadi; Bashdar Mahmud Hussen; Mohammad Taheri; Maryam Rezazadeh
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.